John A. Hickman

14.8k citations

184 papers · 10.8k indexed · 3 hit papers · h-index 50

Impact in

Oncology top 0.5%
- Cancer-related Molecular Pathways
- Cancer Cells and Metastasis
Molecular Biology top 0.5%
- Cell death mechanisms and regulation
- RNA Interference and Gene Delivery
- Cancer therapeutics and mechanisms
- Mitochondrial Function and Pathology
- DNA Repair Mechanisms

Papers in

Toxicology 7
Oncology 54
- Cancer-related Molecular Pathways 29

Co-authors: Caroline Dive Christopher S. Potten Anita J. Merritt James W. Wilson Christine M. Chresta Ian D. Morris A. E. Wakeling P. Roy Walker
Journals: Biochemical Pharmacology (16 papers)Molecular Pharmacology (7 papers)Oncogene (6 papers)Gastroenterology (5 papers)Journal of Medicinal Chemistry (5 papers)
Partner nations: United Kingdom France United States

In The Last Decade

John A. Hickman

182 papers receiving 10.6k citations

Hit Papers

align trajectories log scale

Functional and physical interaction between Bcl‐XL and a BH3‐like domain in Beclin‐1 2007 · 912 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2007 The EMBO Journal
1993 The EMBO Journal
1992 Cancer and Metastasis Reviews

Peers

Countries citing papers authored by John A. Hickman

Since Specialization

Citations

This map shows the geographic impact of John A. Hickman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. Hickman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. Hickman more than expected).

Fields of papers citing papers by John A. Hickman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John A. Hickman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. Hickman. The network helps show where John A. Hickman may publish in the future.

Co-authors

The 25 scholars most cited alongside John A. Hickman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John A. Hickman Line = papers co-authored together John A. Hickman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Precision Medicine for Childhood Cancer: Current Limitations and Future Perspectives JCO Precision Oncology ·Martin G. McCabe, Birgit Geoerger, Louis Chesler, Darren Hargrave, D. Williams Parsons, Cornelis M. van Tilburg, Gudrun Schleiermacher, John A. Hickman, Sally L. George	2024	4
2	Su1755 DIFFERENCES IN FISTULA VOLUME PREDICT NEED FOR PERIANAL SURGERY IN PATIENTS WITH PERIANAL FISTULIZING CROHN'S DISEASE Gastroenterology ·Renate Rabl, S. D. Silver, Suha Abushamma, Radhika Smith, McCoy Rh, John A. Hickman, لاميس فوزى البهنسى, Maria Zulfiqar, Daniel R. Ludwig, Anup S. Shetty, Satish E. Viswanath, David H. Ballard, Parakkal Deepak	2023	1
3	Costs and Causes of Oncology Drug Attrition With the Example of Insulin-Like Growth Factor-1 Receptor Inhibitors JAMA Network Open ·Jacqueline M. Burgette, Leeza Osipenko, Jack W. Scannell, John A. Hickman	2023	22
4	Practical strategies for delivering airway training in the COVID-19 era British Journal of Anaesthesia ·John A. Hickman, Alistair F. McNarry, F. E. Kelly	2021	9
5	Capturing complex tumour biology in vitro: histological and molecular characterisation of precision cut slices Scientific Reports ·Emma Jane Davies, Meng Dong, Matthias Gutekunst, Katja Maria Närhi, Bima Sena Duanda, Sami Blom, Ashwini S. Nagaraj, Tauno Metsalu, Eva Oswald, Sigrun Erkens‐Schulze, Hardoko Hardoko, Riku Turkki, Stephen R. Wedge, Taija M. af Hällström, Julia Schueler, Wytske M. van Weerden, Emmy W. Verschuren, Simon T. Barry, Heiko van der Kuip, John A. Hickman	2015	92
6	S49076 Is a Novel Kinase Inhibitor of MET, AXL, and FGFR with Strong Preclinical Activity Alone and in Association with Bevacizumab Molecular Cancer Therapeutics ·Mike F. Burbridge, Céline Bossard, Jesus Maria Munoz Nieto, Imre Fejes, Alain Bruno, Stéphane Léonce, Gilles Ferry, Georges Da Violante, François Bouzom, Valérie Cattan, 康隆岩月, Paolo M. Comoglio, Brian Lockhart, Jean A. Boutin, Alex Cordi, Melanie B Williams, Alain St. Pierre, John A. Hickman, Francisco Cruzalegui, Stéphane Depil	2013	74
7	N-terminally cleaved Bcl-xL mediates ischemia-induced neuronal death Nature Neuroscience ·Dimitry Ofengeim, Ying‐Bei Chen, Takahiro Miyawaki, Hongmei Li, Silvio Sacchetti, Richard J. Flannery, Kambiz N. Alavian, Fabrizio Pontarelli, Brian A. Roelofs, John A. Hickman, J. Marie Hardwick, R. Suzanne Zukin, Elizabeth A. Jonas	2012	60
8	Bax activation by engagement with, then release from, the BH3 binding site of Bcl-xL. HAL (Le Centre pour la Communication Scientifique Directe) ·France Gauthier, Jeena Habib, Pierre‐François Cartron, Tristan Gallenne, Nicolas Cauquil, Thierry Le Diguarher, Patrick Casara, François M. Vallette, Stéphen Manon, John A. Hickman, Olivier Geneste, Philippe Juin	2011	2
9	Bax Activation by Engagement with, Then Release from, the BH3 Binding Site of Bcl-x _L Molecular and Cellular Biology ·Fabien Gautier, Yannis Guillemin, Pierre‐François Cartron, Tristan Gallenne, Nicolas Cauquil, Thierry Le Diguarher, Patrick Casara, François M. Vallette, Stéphen Manon, John A. Hickman, Olivier Geneste, Philippe Juin	2010	30
10	Frequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cells Breast Cancer Research ·Jason Feliciano, Virginie Maire, Eléonore Gravier, Guillem Rigaill, Anne Vincent‐Salomon, Jung Min Boo, Ingrid Lebigot, O. Andriambeloson, 幸雄村井, Pierre Gestraud, Philippe Hupé, Emmanuel Barillot, Francisco Cruzalegui, Gordon C. Tucker, Marc‐Henri Stern, Jean Paul Thiery, John A. Hickman, Thierry Dubois	2008	170
11	Cellular damage signals promote sequential changes at the N-terminus and BH-1 domain of the pro-apoptotic protein Bak Oncogene ·Gareth Griffiths, Bernard M. Corfe, Peter Savory, Siân H. Leech, Mauro Degli Esposti, John A. Hickman, Caroline Dive	2001	73
12	Damage-induced apoptosis in intestinal epithelia from bcl-2-null and bax-null mice: investigations of the mechanistic determinants of epithelial apoptosis in vivo Oncogene ·D. Mark Pritchard, Christopher S. Potten, Stanley J. Korsmeyer, Fabrizio Turchi, John A. Hickman	1999	89
13	The control of apoptosis through cell-stromal interactions The HKU Scholars Hub (University of Hong Kong) ·Charles Streuli, Juri Schreib, Матвеев С. С., Идрисов Д. В., Матвеев С. Г., Чечет И. В., Семенихин А. С., Анисимов М. Ю., Лукачев С. В., Anthony D. Metcalfe, Andrew Gilmore, Peter Broussinos, John A. Hickman, Caroline Dive	1998	1
14	Changes of Mitochondrial Mass in the Hemopoietic Stem Cell Line FDCP-Mix after Treatment with Etoposide: A Correlative Study by Multiparameter Flow Cytometry and Confocal and Electron Microscopy Experimental Cell Research ·Siegfried Reipert, Jinfeng Xiong, Павлова Лариса Николаевна, John A. Hickman, Terence Allen	1995	47
15	Apoptosis and cancer chemotherapy Philosophical Transactions of the Royal Society B Biological Sciences ·John A. Hickman, C.S. Potten, Anita J. Merritt, Thomas C. Fisher	1994	96
16	The Cell Membrane and Cell Signals as Targets in Cancer Chemotherapy AACR, EORTC, and BACR Special Conference in Cancer Research Cancer Research ·Garth Powis, John A. Hickman, Paul Workman, Thomas R. Tritton, Jean‐Pierre Abita, Wolfgang E. Berdel, Andreas Gescher, Harold L. Moses, Garth L. Nicolson	1990	7
17	The influence of the extracellular matrix on the growth and differentiation of ht 29 human colon adenocarcinoma cells Bangun Tambupolon, K. M. S. Townsend, John A. Hickman	1990	1
18	Characterisation of a Na+/K+/Cl− cotransporter in alkylating agent-sensitive L1210 murine leukemia cells Biochimica et Biophysica Acta (BBA) - Biomembranes ·Carol Wilcock, John A. Hickman	1988	6
19	N-methylformamide (NSC 3051): a potenial candidate for combination chemotherapy European Journal of Cancer and Clinical Oncology ·Simon P. Langdon, John A. Hickman, Andreas Gescher, Malcolm F. G. Stevens, Cui Xiu-zhu, Bao Wenmin	1985	26
20	A comparative study of the anti-tumour activity of N-methylformamide and related compounds. British Journal of Cancer ·Bruna Corrêa [UNIFESP] Nonato, Neil W. Gibson, John A. Hickman, Andreas J. Gescher, Malcolm F. G. Stevens	1981	1

About John A. Hickman

John A. Hickman is a scholar working on Toxicology, Oncology, Molecular Biology, Microbiology and Biotechnology, having authored 184 papers that have together received 10.8k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (38 papers), Cancer-related Molecular Pathways (29 papers), Cancer therapeutics and mechanisms (27 papers), Mitochondrial Function and Pathology (11 papers), RNA Interference and Gene Delivery (10 papers), Cancer Research and Treatments (10 papers), Neuroscience and Neuropharmacology Research (10 papers) and Synthesis and biological activity (9 papers). The work is most often cited by research in Oncology (3.3k citations), Molecular Biology (6.9k citations), Cancer Research (1.4k citations), Toxicology (295 citations) and Biotechnology (598 citations). John A. Hickman has collaborated with scholars based in United Kingdom, France and United States. Frequent co-authors include Caroline Dive, Christopher S. Potten, Anita J. Merritt, James W. Wilson, Christine M. Chresta, Ian D. Morris, A. E. Wakeling, P. Roy Walker, Ian F. Tannock and M. Sikorska. Their work appears in journals such as Biochemical Pharmacology, Molecular Pharmacology, Oncogene, Gastroenterology and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact